Medical-device maker Becton Dickinson and Co. accused a former area sales director of bolting to a competitor in violation of ...

Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that ...

China and Mexico are two of the largest medical equipment manufacturers in the world. The U.S. has imported roughly $10B in ...

Viewing insider transactions for Embecta Corp.'s (NASDAQ:EMBC ) over the last year, we see that insiders were net buyers. This means that a larger number of shares were purchased by insiders in ...

After inking a prove-it deal with the Eagles last offseason, Mekhi Becton is ready to cash in. According to Tony Pauline of Sportskeeda.com, the offensive lineman “is drawing a lot of interest” from ...

Investors in Becton, Dickinson & Co (Symbol: BDX) saw new options begin trading today, for the December 2026 expiration. One of the key data points that goes into the price an option buyer is ...

Embecta's compelling ~44% free cash flow yield offers a strong risk-reward despite headwinds from new insulin technologies and GLP-1 drugs. See more here.

The global Cancer Biomarkers Market is expected to grow at 12.7% CAGR from 2025 to 2032. Latest Research Report on the Cancer Biomarkers Market Size, Status, and Forecast for 2025-2032. In-depth ...

The NFL scouting combine in Indianapolis this week is a pivotal time for the pre-draft process. Teams across the league have narrowed down their draft boards and will be meeting with prospects for ...